Raquel M. Quigua Orozco

Raquel M. Quigua Orozco

Auto-generated profile, based on publicly available information

Raquel M. Quigua Orozco

S-Inova Biotech, Programa de Pós-Graduação em Biotecnologia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
Marlon CardosoMarlon Cardoso
Marlon Cardoso
RORaquel Q. Orozco
Raquel Q. Orozco
SRSamilla B. Rezende
Samilla B. Rezende
GRGisele Rodrigues
Gisele Rodrigues
KOKaren G. N. Oshiro
Karen G. N. Oshiro
Octavio FrancoOctavio Franco
Octavio Franco
Antimicrobial peptides (AMPs), especially antibacterial peptides, have been widely investigated as potential alternatives to antibiotic-based therapies. Indeed, naturally occurring and synthetic AMPs have shown promising results against a series of clinically relevant bacteria. Even so, this class of antimicrobials has continuously failed clinical trials at some point, highlighting the importance of AMP optimization. In this context, the computer-aided design of AMPs has put together crucial information on chemical parameters and bioactivities in AMP sequences, thus providing modes of prediction to evaluate the antibacterial potential of a candidate sequence before synthesis. Quantitative structure-activity relationship (QSAR) computational models, for instance, have greatly contributed to AMP sequence optimization aimed at improved biological activities. In addition to machine-learning methods, the de novo design, linguistic model, pattern insertion methods, and genetic algorithms, have shown the potential to boost the automated design of AMPs. However, how successful have these approaches been in generating effective antibacterial drug candidates? Bearing this in mind, this review will focus on the main computational strategies that have generated AMPs with promising activities against pathogenic bacteria, as well as anti-infective potential in different animal models, including sepsis and cutaneous infections. Moreover, we will point out recent studies on the computer-aided design of antibiofilm peptides. As expected from automated design strategies, diverse candidate sequences with different structural arrangements have been generated and deposited in databases. We will, therefore, also discuss the structural diversity that has been engendered.

2 February 2026 in JACS Au
Verified
Journal Article
Open access
JPJoão P. F. Pimentel
João P. F. Pimentel
RORaquel M. Quigua Orozco
Raquel M. Quigua Orozco
SRSamilla Beatriz de Rezende
Samilla Beatriz de Rezende
LLLucas Lima
Lucas Lima
Marlon CardosoMarlon Cardoso
Marlon Cardoso
Antimicrobial resistance (AMR) poses a critical global health threat, demanding innovative strategies for drug discovery. Antimicrobial peptides (AMPs) represent promising alternatives, yet traditional experimental identification is limited by cost and scalability. Advances in artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), have transformed AMP discovery by enabling the accurate prediction, design, and optimization of novel candidates. This perspective highlights recent progress in AI-driven approaches, including predictive models and generative models, which accelerate large-scale peptide screening and functional annotation. We further emphasize the integration of multiomics data and the potential role of emerging technologies, such as quantum computing (QC), in overcoming computational bottlenecks for peptide design. Together, these approaches promise to expand the therapeutic landscape, paving the way toward next-generation peptide-based antimicrobials capable of circumventing resistance mechanisms and addressing urgent clinical needs.

23 May 2024 in Journal of Bacteriology
Verified
Journal Article
Closed access
RORaquel M Q Orozco
Raquel M Q Orozco
KOKaren G N Oshiro
Karen G N Oshiro
IPIngrid B Pinto
Ingrid B Pinto
Danieli Fernanda BucciniDanieli Fernanda Buccini
Danieli Fernanda Buccini
CAClaudiane V Almeida
Claudiane V Almeida
Octavio FrancoOctavio Franco
Octavio Franco
Bovine mastitis is a frequent infection in lactating cattle, causing great economic losses. Staphylococcus aureus represents the main etiological agent, which causes recurrent and persistent intramammary infections because conventional antibiotics are ineffective against it. Mastoparan-like peptides are multifunctional molecules with broad antimicrobial potential, constituting an attractive alternative. Nevertheless, their toxicity to host cells has hindered their therapeutic application. Previously, our group engineered three mastoparan-L analogs, namely mastoparan-MO, mastoparan-R1, and [I 5 , R 8 ] MP, to improve cell selectivity and potential. Here, we were interested in comparing the antibacterial efficacy of mastoparan-L and its analogs against bovine mastitis isolates of S. aureus strains, making a correlation with the physicochemical properties and structural arrangement changes promoted by the sequence modifications. As a result, the analog’s hemolytic and/or antimicrobial activity was balanced. All the peptides displayed α-helical folding in hydrophobic and membrane-mimetic environments, as determined by circular dichroism. The peptide [I 5 , R 8 ] MP stood out for its enhanced selectivity and antibacterial features related to mastoparan-L and the other derivatives. Biophysical approaches revealed that [I 5 , R 8 ] MP rapidly depolarizes the bacterial membrane of S. aureus , causing cell death by subsequent membrane disruption. Our results demonstrated that the [I 5 , R 8 ] MP peptide could be a starting point for the development of peptide-based drugs for the treatment of bovine mastitis, with the advantage of no residue in milk, which would help reduce the use of classical antibiotics. IMPORTANCE: Staphylococcus aureus is a leading cause of mastitis, the world’s most important dairy cattle disease. The multidrug resistance and zoonotic potential of S. aureus , besides the likelihood of antibiotic residues in milk, are of critical concern to public and animal health. Antimicrobial peptides offer a novel antimicrobial strategy. Here, we demonstrate that [I 5 , R 8 ] MP is a potent and selective peptide, which acts on S. aureus by targeting the bacterial membrane. Therefore, understanding the physicochemical determinants and the modes of action of this class of antimicrobials opens novel prospects for peptide development with enhanced activities in the bovine mastitis context.

24 July 2024 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
RQRaquel M. Quigua‐Orozco
Raquel M. Quigua‐Orozco
IAIsadora E. P. Andrade
Isadora E. P. Andrade
KOKaren G. N. Oshiro
Karen G. N. Oshiro
SRSamilla B. Rezende
Samilla B. Rezende
ASAlexandre Duarte O. Santos
Alexandre Duarte O. Santos
Octavio FrancoOctavio Franco
Octavio Franco

5 May 2026 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Open access
RORaquel M. Quigua Orozco
Raquel M. Quigua Orozco
ASAlexandre D. O. Santos
Alexandre D. O. Santos
JRJoelma P. Rossetto
Joelma P. Rossetto
EMElisângela S. Madalozzo
Elisângela S. Madalozzo
LLLívia V. Luchi
Lívia V. Luchi
Marlon CardosoMarlon Cardoso
Marlon Cardoso
Advances in computational design have greatly accelerated antimicrobial peptide engineering. In this study, three Plasmodium chabaudi-derived peptides (PcDBS1R1, PcDBS1R5, and PcDBS1R9), generated using the Joker computational design algorithm, were synthesized and characterized for their structural and functional properties. Biophysical analyses revealed that PcDBS1R5 and PcDBS1R9 predominantly adopted α-helical structures with high amphipathicity, whereas PcDBS1R1 exhibited greater structural plasticity. PcDBS1R5 and PcDBS1R9 displayed antibacterial activity against an Acinetobacter baumannii clinical isolate, whereas PcDBS1R1 showed pronounced antibiofilm effects. None of the peptides exhibited cytotoxicity toward murine macrophages, and all significantly reduced nitric oxide production in lipopolysaccharide-stimulated macrophages, suggesting potential anti-inflammatory activity. Overall, these findings demonstrate that computer-aided design of P. chabaudi-derived peptides can yield molecules with antibiofilm, and immunomodulatory properties, minimal cytotoxicity, and promising therapeutic potential as scaffolds for next-generation peptide-based treatments targeting biofilm-associated bacterial infections.